Laryngo-onycho-cutaneous Syndrome
Overview
Authors
Affiliations
Laryngo-onycho-cutaneous (LOC) syndrome was reclassified as a subtype of junctional epidermolysis bullosa (JEB) based on clinical features similar to JEB and its association, in the majority of patients from the Punjab, with a unique mutation affecting the N terminus of the alpha3 chain of LM332. Although LOC syndrome is now a subtype of JEB(JEB-LOC) JEB-LOC has a distinct clinicopathologic appearance and molecular fingerprint. The intricacies of the JEB-LOC subtype are discussed in this article with regard to disease presentation, pathogenesis, management, and prognosis.
Of LAMA3 and LAMB3: A novel gene therapy for epidermolysis bullosa.
OConnell P Mol Ther. 2024; 32(5):1197-1198.
PMID: 38631349 PMC: 11081916. DOI: 10.1016/j.ymthe.2024.04.014.
Lau C, Rouhani M, Maughan E, Orr J, Kolluri K, Pearce D Mol Ther. 2024; 32(5):1497-1509.
PMID: 38429928 PMC: 11081864. DOI: 10.1016/j.ymthe.2024.02.032.
Laryngo-Onycho-Cutaneous Syndrome (LOCS).
Hemani F, Khurram U, Naveed A Pak J Med Sci. 2024; 40(2ICON Suppl):S100-S102.
PMID: 38328664 PMC: 10844917. DOI: 10.12669/pjms.40.2(ICON).9035.
Khan F, Khan N, Rehman S, Ejaz A, Ali U, Erfan M Biomolecules. 2021; 11(5).
PMID: 33921969 PMC: 8143555. DOI: 10.3390/biom11050620.
Supraglottic cyst in adult patient with Shabbir syndrome.
Kajal S, Reddy C, Sikka K, Thakar A BMJ Case Rep. 2020; 13(12).
PMID: 33334763 PMC: 7747537. DOI: 10.1136/bcr-2020-238212.